v3.26.1
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 6 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Cash flows from operating activities    
Net loss $ (40,690) $ (29,799)
Adjustments to reconcile net loss to net cash provided by (used in) operating activities:    
Depreciation and amortization 22,497 21,342
Stock-based compensation 11,501 12,351
Foreign currency transaction loss (gain) 1,231 (9,137)
Share in net (profits) losses of associated companies 0 4,038
Unrealized Gain (Loss) on Investments (59) 240
Acquisitions (4,045) 862
Deferred income taxes, net and uncertain tax positions 5,568 305
Other non-cash items, net (1,065) (53)
Change in cash attributable to changes in operating assets and liabilities:    
Accounts receivable, net (9,240) (1,951)
Inventories 170 20,439
Other current assets and prepaid expenses (8,113) (6,429)
Other non-current assets 1,487 3,909
Accounts payable 2,472 (9,213)
Other current liabilities 4,203 (4,898)
Deferred revenues 533 4,484
Other non-current liabilities (2,745) (3,059)
Net cash provided by (used in) operating activities (16,295) 3,431
Cash flows from investing activities    
Cash paid for business combinations 0 (5,448)
Purchase of property and equipment (7,578) (11,036)
Investments in short-term bank deposits (126,000) (183,500)
Proceeds from Sale of Short-Term Investments 156,000 80,500
Investments in unconsolidated entities (4,933) (390)
Purchase of intangible assets (1,180) (4,028)
Other investing activities 397 (41)
Net cash used in investing activities 16,706 (123,943)
Cash flows from financing activities    
Payment of contingent consideration (2,624) (657)
Proceeds from PIPE transaction, net of issuance costs 0 119,291
Other financing activities 56 (350)
Net cash provided by (used in) financing activities (2,568) 118,284
Effect of exchange rate changes on cash, cash equivalents and restricted cash 42 3,069
Net change in cash, cash equivalents and restricted cash (2,115) 841
Cash, cash equivalents and restricted cash, beginning of year 95,356 71,076
Cash, cash equivalents and restricted cash, end of year 93,241 71,917
Non-cash investing and financing activities:    
Transfer of inventories to fixed assets 607 2,773
Transfer of fixed assets to inventories 0 5
Issuance of ordinary shares under employee share purchase plan 2,743 2,598
Issuance of ordinary shares as part of Nexa3D Inc. transaction 500 3,135
Reconciliation of cash, cash equivalents and restricted cash reported in the consolidated balance sheets:    
Cash and cash equivalents 92,528 71,073
Restricted cash included in other current assets 713 844
Total cash, cash equivalents and restricted cash shown in the consolidated statement of cash flows $ 93,241 $ 71,917